Interaction between P-TEFb and the C-Terminal Domain of RNA Polymerase II Activates Transcriptional Elongation from Sites Upstream or Downstream of Target Genes

REFERENCES

• Barboric, M., R. M. Nissen, S. Kanazawa, N. Jabrane-Ferrat, and B. M. Peterlin. 2001. NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8: 327–337.
   PubMed Web of Science ®Google Scholar
• Bentley, D. 1999. Coupling RNA polymerase II transcription with pre-mRNA processing. Curr. Opin. Cell Biol. 11: 347–351.
   PubMedGoogle Scholar
• Bieniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1998. Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J. 17: 7056–7065.
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and J. T. Kadonaga. 1998. Going the distance: a current view of enhancer action. Science 281: 61–63.
   Google Scholar
• Conaway, J. W., A. Shilatifard, A. Dvir, and R. C. Conaway. 2000. Control of elongation by RNA polymerase II. Trends Biochem. Sci. 25: 375–380.
   PubMedGoogle Scholar
• Dynan, W. S. 1989. Modularity in promoters and enhancers. Cell 58: 1–4.
   PubMedGoogle Scholar
• Fong, Y. W., and Q. Zhou. 2000. Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter. Mol. Cell. Biol. 20: 5897–5907.
   PubMed Web of Science ®Google Scholar
• Fu, T. J., J. Peng, G. Lee, D. H. Price, and O. Flores. 1999. Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription. J. Biol. Chem. 274: 34527–34530.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., T. P. Cujec, J. Peng, J. Garriga, D. H. Price, X. Grana, and B. M. Peterlin. 1998. The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat. J. Virol. 72: 7154–7159.
   PubMed Web of Science ®Google Scholar
• Fujinaga, K., R. Taube, J. Wimmer, T. P. Cujec, and B. M. Peterlin. 1999. Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T. Proc. Natl. Acad. Sci. USA 96: 1285–1290.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., and K. A. Jones. 1999. HIV-1 Tat: coping with negative elongation factors. Curr. Opin. Immunol. 11: 460–465.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20: 6958–6969.
   PubMed Web of Science ®Google Scholar
• Garber, M. E., P. Wei, V. N. KewalRamani, T. P. Mayall, C. H. Herrmann, A. P. Rice, D. R. Littman, and K. A. Jones. 1998. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev. 12: 3512–3527.
   PubMed Web of Science ®Google Scholar
• Gerber, H. P., M. Hagmann, K. Seipel, O. Georgiev, M. A. West, Y. Litingtung, W. Schaffner, and J. L. Corden. 1995. RNA polymerase II C-terminal domain required for enhancer-driven transcription. Nature 374: 660–662.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., M. J. Selby, and B. M. Peterlin. 1993. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. J. Mol. Biol. 23: 610–619.
   Google Scholar
• Greenblatt, J., J. R. Nodwell, and S. W. Mason. 1993. Transcriptional antitermination. Nature 364: 401–406.
   PubMed Web of Science ®Google Scholar
• Hampsey, M., and D. Reinberg. 1999. RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Gene Dev. 9: 132–139.
   PubMed Web of Science ®Google Scholar
• Harrich, D., J. Garcia, R. Mitsuyasu, and R. Gaynor. 1990. TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes EMBO J. 9: 4417–4423.
   PubMedGoogle Scholar
• Hartzog, G. A., T. Wada, H. Handa, and F. Winston. 1998. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNAPII. Genes Dev. 12: 357–369.
   PubMed Web of Science ®Google Scholar
• Herr, W. 1993. The SV-40 enhancer: transcriptional regulation through a hierarchy of combinatorial interactions. Semin. Virol. 4: 3–15.
   Google Scholar
• Ivanov, D., Y. T. Kwak, J. Guo, and R. B. Gaynor. 2000. Domains in the SPT5 protein that modulate its transcriptional regulatory properties. Mol. Cell. Biol. 20: 2970–2983.
   PubMed Web of Science ®Google Scholar
• Ivanov, D., Y. T. Kwak, E. Nee, J. Guo, L. F. Garcia-Martinez, and R. B. Gaynor. 1999. Cyclin T1 domains involved in complex formation with Tat and TAR RNA. J. Mol. Biol. 288: 41–56.
   PubMedGoogle Scholar
• Johnson, P. F., and S. L. McKnight. 1989. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 58: 799–839.
   PubMed Web of Science ®Google Scholar
• Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63: 717–743.
   PubMed Web of Science ®Google Scholar
• Kanazawa, S., T. Okamoto, and B. M. Peterlin. 2000. Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12: 61–70.
   PubMedGoogle Scholar
• Kao, S. Y., A. F. Calman, P. A. Luciw, and B. M. Peterlin. 1987. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330: 489–493.
   PubMed Web of Science ®Google Scholar
• Kim, J. B., and P. A. Sharp. 2001. P-TEFb phosphorylates hSPT5 and RNA polymerase II CTD independently of CAK. J. Biol. Chem. 276: 12317–12323.
   PubMed Web of Science ®Google Scholar
• Kim, J. B., Y. Yamaguchi, T. Wada, H. Handa, and P. A. Sharp. 1999. Tat-SF1 protein associates with RAP30 and human SPT5 proteins. Mol. Cell. Biol. 19: 5960–5968.
   PubMedGoogle Scholar
• Laspia, M. F., P. Wendel, and M. B. Mathews. 1993. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro. J. Mol. Biol. 232: 732–746.
   PubMedGoogle Scholar
• Lee, D. K., D. O. Duan, and C. Chang. 2001. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. J. Biol. Chem. 276: 9978–9984.
   PubMed Web of Science ®Google Scholar
• Lemon, B., and R. Tjian. 2000. Orchestrated response: a symphony of transcription factors for gene control. Genes Dev. 14: 2551–2569.
   PubMed Web of Science ®Google Scholar
• Lis, J. 1998. Promoter-associated pausing in promoter architecture and postinitiation transcriptional regulation. Cold Spring Harbor Symp. Quant. Biol. 63: 347–356.
   PubMedGoogle Scholar
• Lis, J. T., P. Mason, J. Peng, D. H. Price, and J. Werner. 2000. P-TEFb kinase recruitment and function at heat shock loci. Genes Dev. 14: 792–803.
   PubMed Web of Science ®Google Scholar
• Majello, B., G. Napolitano, A. Giordano, and L. Lania. 1999. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo. Oncogene 18: 4598–4605.
   PubMed Web of Science ®Google Scholar
• Meininghaus, M., R. D. Chapman, M. Horndasch, and D. Eick. 2000. Conditional expression of RNA polymerase II in mammalian cells. Deletion of the carboxyl-terminal domain of the large subunit affects early steps in transcription. J. Biol. Chem. 275: 24375–24382.
   PubMedGoogle Scholar
• Muller, M. M., T. Gerster, and W. Schaffner. 1988. Enhancer sequences and the regulation of gene transcription. Eur. J. Biochem. 176: 485–495.
   PubMedGoogle Scholar
• Napolitano, G., B. Majello, P. Licciardo, A. Giordano, and L. Lania. 2000. Transcriptional activity of positive transcription elongation factor b kinase in vivo requires the C-terminal domain of RNA polymerase II. Gene 254: 139–145.
   PubMed Web of Science ®Google Scholar
• Okamoto, H., C. T. Sheline, J. L. Corden, K. A. Jones, and B. M. Peterlin. 1996. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA 93: 11575–11579.
   PubMedGoogle Scholar
• Orphanides, G., T. Lagrange, and D. Reinberg. 1996. The general transcription factors of RNA polymerase II. Genes Dev. 10: 2657–2683.
   PubMed Web of Science ®Google Scholar
• Pazin, M. J., P. L. Sheridan, K. Cannon, Z. Cao, J. G. Keck, J. T. Kadonaga, and K. A. Jones. 1996. NF-kappa B-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Genes Dev. 10: 37–49.
   PubMedGoogle Scholar
• Peng, J., N. F. Marshall, and D. H. Price. 1998. Identification of a cyclin subunit required for the function of Drosophila P-TEFb. J. Biol. Chem. 273: 13855–13860.
   PubMed Web of Science ®Google Scholar
• Peng, J., Y. Zhu, J. T. Milton, and D. H. Price. 1998. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12: 755–762.
   PubMed Web of Science ®Google Scholar
• Pierce, J. W., M. Lenardo, and D. Baltimore. 1988. Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA 85: 1482–1486.
   PubMed Web of Science ®Google Scholar
• Ping, Y. H., and T. M. Rana. 2000. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 276: 12951–12958.
   PubMedGoogle Scholar
• Price, D. H. 2000. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20: 2629–2634.
   PubMed Web of Science ®Google Scholar
• Raschke, E. E., T. Albert, and D. Eick. 1999. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II. J. Immunol. 163: 4375–4382.
   PubMedGoogle Scholar
• Reinberg, D., G. Orphanides, R. Ebright, S. Akoulitchev, J. Carcamo, H. Cho, P. Cortes, R. Drapkin, and O. Flores. 1998. The RNA polymerase II general transcription factors: past, present, and future. Cold Spring Harbor Symp. Quant. Biol. 63: 83–103.
   PubMedGoogle Scholar
• Reines, D., R. C. Conaway, and J. W. Conaway. 1999. Mechanism and regulation of transcriptional elongation by RNA polymerase II. Curr. Opin. Cell Biol. 11: 342–346.
   PubMed Web of Science ®Google Scholar
• Seipel, K., O. Georgiev, H. P. Gerber, and W. Schaffner. 1993. C-terminal domain (CTD) of RNA-polymerase II and N-terminal segment of the human TATA binding protein (TBP) can mediate remote and proximal transcriptional activation, respectively. Nucleic Acids Res. 21: 5609–5615.
   PubMedGoogle Scholar
• Seipel, K., O. Georgiev, H. P. Gerber, and W. Schaffner. 1994. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a “portable enhancer domain”? Mol. Reprod. Dev. 39: 215–225.
   PubMedGoogle Scholar
• Seipel, K., O. Georgiev, and W. Schaffner. 1992. Different activation domains stimulate transcription from remote (‘enhancer’) and proximal (‘promoter’) positions. EMBO J. 11: 4961–4968.
   PubMedGoogle Scholar
• Sheridan, P. L., C. T. Sheline, K. Cannon, M. L. Voz, M. J. Pazin, J. T. Kadonaga, and K. A. Jones. 1995. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev. 9: 2090–2104.
   PubMed Web of Science ®Google Scholar
• Southgate, C. D., and M. R. Green. 1991. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 5: 2496–2507.
   PubMedGoogle Scholar
• Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75: 135–146.
   PubMed Web of Science ®Google Scholar
• Strobl, L. J., and D. Eick. 1992. Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J. 11: 3307–3314.
   PubMed Web of Science ®Google Scholar
• Taube, R., K. Fujinaga, J. Wimmer, M. Barboric, and B. M. Peterlin. 1999. Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology 264: 245–253.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Takagi, Y. Yamaguchi, A. Ferdous, T. Imai, S. Hirose, S. Sugimoto, K. Yano, G. A. Hartzog, F. Winston, S. Buratowski, and H. Handa. 1998. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12: 343–356.
   PubMed Web of Science ®Google Scholar
• Wada, T., T. Takagi, Y. Yamaguchi, D. Watanabe, and H. Handa. 1998. Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17: 7395–7403.
   PubMed Web of Science ®Google Scholar
• Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451–462.
   PubMed Web of Science ®Google Scholar
• West, M. J., and J. Karn. 1999. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer, EMBO J. 18: 1378–1386.
   PubMedGoogle Scholar
• Wu-Baer, F., W. S. Lane, and R. B. Gaynor. 1998. Role of the human homolog of the yeast transcription factor SPT5 in HIV-1 Tat-activation. J. Mol. Biol. 277: 179–197.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, Y., T. Takagi, T. Wada, K. Yano, A. Furuya, S. Sugimoto, J. Hasegawa, and H. Handa. 1999. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97: 41–51.
   PubMed Web of Science ®Google Scholar